• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: June 27 - July 1, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

June 27 - July 1, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/28/11Washington, DCN/AJim Greenwood (Biotechnology Industry Organization - BIO)Biotechnology
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products6/27/11-6/29/11Phoenix, AZSeveral FDA Officials and Staff MembersPublicCenter for Tobacco Products Stakeholders Session - American Indians/Alaska Natives
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Caroline Lewis, Acting Deputy Commissioner for Administration6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs6/29/11Washington, DCN/AN/ASpeech: BIO International Conference - EMA/FDA Town Hall
Karen Midthun, M.D.,  Director, Center for Biologics Evaluation and Research6/28/11-6/29/11Silver Spring, MDSeveral FDA Officials and Staff MembersSeveral representatives from Genentech and the publicAvastin Hearing
Meghan Scott, Acting Associate Commissioner for External Affairs6/27/11Silver Spring, MDLesley MaloneyAnn Amstutz Hayes (Scholastic InSchool); Karen Stone (American Continental Group)Opportunities for Health Communications to Children and Youth
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health6/27/11Washington, DCSeveral FDA Officials and Staff MembersSeveral Representatives of the National Organization for Rare Disorders (NORD)Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research6/25/11-6/29/11Coronado, CAN/AN/A51st Annual Meeting of the Teratology Society
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods6/30/11Washington, DCSeveral FDA Officials and Staff MembersSarah Norman, Devin Richardson, Joe Jankiewicz, Melinda Cep, Brian Laughlin, Stephen Cha, Eric Flamm, Chelsea Render, Brooke Jamison, Terry Ryan KaneFDA Guidance 209, Cephalosporin, and Antimicrobial Resistance
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods6/30/11Washington, DCSeveral FDA Officials and Staff MembersHouse Majority Staff of Energy & Commerce, Agriculture, and Small Business CommitteesCephalosporin
Ralph Tyler, J.D., Chief Counsel6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs6/27/11-7/1/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/27/11-7/1/11N/AN/AN/ANo Significant Meetings